Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Live Discussions
Live Discussions

Updated 17 February 2011

Stress Granules and Neurodegenerative Disease—What’s the Scoop?


Ben Wolozin

Daryl Bosco

Aaron Gitler

Dorothee Dormann
The formation of cytoplasmic inclusions called stress granules is one of nature’s many ways of coping with adverse situations. It appears that these inclusions sequester non-essential messenger RNAs, allowing cells to focus on making proteins, such as chaperones, that protect against a variety of stressful insults. Recent work suggests that stress granules may figure in the pathogenesis of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, where stress granule markers decorate pathological protein aggregates in affected neurons. What do stress granules do in disease? Are they part of the problem or part of the solution? What about AD?


TDP-43 in stress granules
Image caption: In human neuroblastoma cells transfected with TDP-43, inclusions (arrows) test positive for both TDP-43 (green) and the stress granule marker TIA-1 (red).
View larger image

This Webinar on stress granules and their relevance to neurodegeneration was led by Ben Wolozin, Boston University; Daryl Bosco, University of Massachusetts Medical Center, Worcester; and Dorothee Dormann, Ludwig-Maximilians-University, Munich, Germany. Aaron Gitler, University of Pennsylvania, Philadelphia, joined them for a panel discussion.

Ben Wolozin's Presentation

Daryl Bosco's Presentation

Dorothee Dormann's Presentation

All Presentations


Background Text
Tom Fagan

Never heard of stress granules? Not to worry; they are new to the neurodegeneration scene, and that is why we are featuring them in this discussion. Stress granules are cytoplasmic inclusions of proteins that play key roles in translation of messenger RNA. They form naturally when a cell deals with stress, such as heat shock, oxygen deprivation, or oxidative damage. They can also be experimentally induced by knocking down (Mokas et al., 2009) or inhibiting (Kedersha et al., 1999) key translation factors, or by overexpressing proteins or adding drugs that block translation (Dang et al., 2006; Mazroui et al., 2006). The precise role of stress granules is unclear, but one theory is that they sequester mRNA transcripts that are not used in coping with stress (see Anderson and Kedersha, 2008). Stress granules dissipate when the stress has passed, and their disassembly correlates with the resumption of general protein synthesis (Mazroui et al., 2007).

These granules contain many of the proteins that are involved in translation, including ribosomal subunits and translational initiation factors such as eukaryotic initiation factors 2, 3, and 4. They also contain polyA mRNA and polyA binding proteins (for a review, see Anderson and Kedersha, 2006) and other components that seem to recruit mRNA to the granules, such as T cell intracellular antigen 1 (TIA-1) and RasGAP-associated endoribonuclease (G3BP). Proteins implicated in neurodegenerative or neurologic diseases have also been linked to these bodies. Ataxin-2, which causes a form of spinocerebellar ataxia when mutated, and survival motor neuron (SMN), the protein at the root of spinal muscular atrophy, both disrupt stress granule formation (Nonhoff et al., 2007; Hua and Zhou, 2004). SMN binds to stress granule proteins, as does huntingtin (Waelter et al., 2001) and prion protein (Goggin et al., 2008). There also seems to be a link between stress granules and the fragile X mental retardation protein (FMRP), whose normal role is to repress translation of RNA in dendrites. FMRP associates with RNAs and proteins found in stress granules (Vanderklish and Edelman, 2005; Linder et al., 2008), and mutations in FMRP protein that cause fragile X syndrome also disrupt these inclusions (Didiot et al., 2008).

More recently, researchers linked stress granules to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration. Wolozin and colleagues reported that the RNA-binding protein TDP-43 gets incorporated into stress granules (see ARF related news story on Liu-Yesucevitz et al., 2010). TDP-43 mutations have emerged as a cause of a small subset of familial ALS cases and some cases of frontotemporal dementia, and aggregates of the protein occur in a majority of ALS cases studied on autopsy. TDP-43 appears to interact with TIA-1, both directly and via RNA. In postmortem tissue from people with ALS and FTLD-U, TDP-43 also colocalizes in inclusions containing TIA-1 and eukaryotic initiation factor 3, suggesting that the TDP-43 inclusions formed in these diseases are stress granules. Interestingly, Gitler and colleagues reported that ataxin-2, normally associated with ataxia, increases a person’s risk for ALS when it undergoes a moderate polyglutamate expansion (Elden et al., 2010). Since ataxin-2 binds stress granules, this strengthens the link between those inclusions and ALS.

Further support for the involvement of these granules in ALS comes from Bosco’s lab and also from Christian Haass’ lab at Ludwig-Maximilians-University, Munich, Germany. Both found that mutants of another RNA binding protein that causes familial ALS, fused in sarcoma (FUS), also end up in stress granules (Dorman et al., 2010 and Bosco et al., 2010). Bosco’s group in collaboration with Larry Hayward, also at UMass Medical Center, found that in cell and zebrafish models of ALS, FUS is more likely to end up in these granules when the scientists apply additional stress, for example, heat shock or oxidative damage.

How do these stress granules fit in with the pathology of ALS/FTLD? Do mutants of TDP-43 and FUS simply make cells more vulnerable to stress, or is there more to the story? What about other neurodegenerative diseases, for example, Alzheimer’s?



  Submit a Comment on this Live Discussion
Cast your vote and/or make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.

View Webinar Instructions

Early Detection Survey Results
The Alzheimer Disease Early Detection Surveys were designed to gauge perceptions and knowledge of early detection of Alzheimer disease as a follow-up to our Early Detection Webinar. The surveys were developed in collaboration with the Geoffrey Beene Foundation.
View Researcher Survey Results [.pdf].
View Public Survey Results [.pdf].
AlzPossible Initiative
The AlzPossible Initiative is an innovative "center without walls" that enables skilled individuals to share their knowledge about best practices in Alzheimer caregiving through this open forum.
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad